Filtered By:
Cancer: Pancreatic Cancer
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 424 results found since Jan 2013.
Building Sustainable Partnerships To Improve Access To Breast Cancer Treatment For Uninsured Women
Breast cancer is a terrifying disease for most women. In the United States, it is the leading cause of cancer deaths among women ages twenty to fifty-nine years. More than 5,100 women are diagnosed with—and at least 1,100 women die from—breast cancer in New York City each year. The breast cancer survival rate is also lower for uninsured women than for those with private health insurance coverage.
Although access to affordable breast cancer screening and treatment has grown substantially over the past few years as a result of increased health insurance coverage options through the Affordable Care Act (ACA), many uninsur...
Source: Health Affairs Blog - June 20, 2017 Category: Health Management Authors: Kumbirai M. Madondo, Janice Zaballero and José Pagán Tags: Costs and Spending Featured GrantWatch Health Professionals Insurance and Coverage Access breast cancer Consumers Health Care Costs Health Care Delivery Health Philanthropy Health Promotion and Disease PreventionGW Hospitals imag Source Type: blogs
The Top 10 Trends Shaping the Future of Pharma
The drug sends a message to a caregiver after the patient swallowed it. The doctor prescribes virtual reality treatments for migraines. Do you think it is science fiction? You are mistaken. Just let me familiarize you with the top 10 trends shaping the future of pharma.
I gave a speech recently to an audience of professionals working in healthcare regulation for the invitation of the Consumer Healthcare Products Association in Washington. After the keynote, a guy raised his hand and asked me the following: how can a regulatory agency keep up with the speed of new technologies in pharma? I get a lot of questions like this o...
Source: The Medical Futurist - June 20, 2017 Category: Information Technology Authors: nora Tags: Future of Medicine Future of Pharma 3d printing artificial intelligence augmented reality digital health gc4 Innovation nanotechnology Personalized medicine pharmacies pharmacogenetics pharmacology virtual reality VR Source Type: blogs
How important is Vitamin D?
FACT: A vitamin D deficiency may result in as much as a 50 percent increased potential for diabetes.
FACT: A vitamin D deficiency puts you at a higher risk for cancer, especially breast, prostate, colon, ovarian, and melanoma.
VITAMIN D DEFICIENCY is a widespread phenomenon with significant implications for health. In modern society vitamin D deficiency is the rule, rather than the exception. While we can blame more severe cases of deficiency on grains, it also commonly occurs independent of grain consumption. The restoration of vitamin D levels is second only to grain elimination when considering the most powerful healthy...
Source: Wheat Belly Blog - June 13, 2017 Category: Cardiology Authors: Dr. Davis Tags: Cancer Depression Diabetes News & Updates Undoctored Vitamin D Weight loss Source Type: blogs
Studying the Beneficial Effects of Intermittent Fasting and Calorie Restriction
This article from the more scientific end of the popular science press covers recent research into the beneficial effects of calorie restriction and intermittent fasting in humans. These interventions have been shown to extend life and improve health in near all species tested to date, slowing measures of aging along the way. This area of the field has grown in recent years, with the addition of a fair amount of new human data. Fasting and low calorie diets have been tested as adjuvants for cancer treatment, for example, and as independent ways to improve metrics of health.
When external calories stop fueling an a...
Source: Fight Aging! - June 8, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Fight Aging! Newsletter, June 5th 2017
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - June 4, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
An Interview with Orthopaedic Oncologist Dr. Vincent Ng
Dr. Vincent Ng is an orthopaedic oncologist with the University of Maryland Greenebaum Comprehensive Cancer Center and an Assistant Professor or Orthopaedics with the University of Maryland School of Medicine. Dr. Ng specializes in treating bone cancer and soft tissue sarcoma. Below he answers common questions about orthopaedic oncology.
What is an orthopaedic oncologist? How do they differ from surgical oncologists?
“An orthopaedic oncologist specializes in bone and soft tissue tumors. I treat any adult or pediatric patient with any bone or soft tissue tumor/lesion/mass, whether benign or malignant, whether it is...
Source: Life in a Medical Center - June 2, 2017 Category: Universities & Medical Training Authors: UMMC Tags: Cancer Doctors bone cancer oncology orthopedics Source Type: blogs
SIWA Therapeutics Obtains Funding to Continue with an Immunotherapy Approach to Clearance of Senescent Cells
SIWA Therapeutics is one of the older companies in the field of cellular senescence, among the small number of ventures that made an attempt to target senescent cells for destruction a decade ago and didn't really get all that far before funding ran out. Times have changed, however, and these groups have now been invigorated by progress in the science of cellular senescence and demonstrations of turning back aging and age-related disease in animal studies. One of these older ventures transformed into Unity Biotechnology, and Unity's success in raising a very large amount of venture funding has made it that much easier for ...
Source: Fight Aging! - May 22, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Health Datapalooza 2017 Day 1: Data Liberation, Sharing, and Analytics
Welcome to Medgadget‘s coverage of Health Datapalooza 2017, an AcademyHealth event, in Washington, DC. The now annual event was launched in 2010 by the Obama administration as a hackathon-style program where attendees were challenged to deve...
Source: Medgadget - May 1, 2017 Category: Medical Equipment Authors: Michael Batista Tags: Exclusive Source Type: blogs
Fight Aging! Newsletter, May 1st 2017
In this study we demonstrate the use of clustered regularly interspaced short palindromic repeats (CRISPR)-based epigenome editing to alter cell response to inflammatory environments by repressing inflammatory cytokine cell receptors, specifically TNFR1 and IL1R1. This has applications for many inflammatory-driven diseases. It could be applied for arthritis or to therapeutic cells that are being delivered to inflammatory environments that need to be protected from inflammation."
In chronic back pain, for example, slipped or herniated discs are a result of damaged tissue when inflammation causes cells to create molec...
Source: Fight Aging! - April 30, 2017 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
High rate of tumor shrinkage amongst pancreatic cancer patients: study
Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for individuals with advanced pancreatic cancer, according to the results of a pilot clinical demo conducted by the HonorHealth Research Start and the Translational Genomics Research Start (TGen).
Related Posts:Radioimmunotherapy, Gemcitabine combination shows early…Tucatinib (ONT-380) progressing in pivotal demo against…Fox Chase trial tests promising therapy in early breast…New nanopharmaceutical may help overcome resistance to…The antibody that normalizes tumor vesselsThe po...
Source: My Irritable Bowel Syndrome Story - April 25, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
An Approach to Deliver Chimeric Antigen Receptor T Cells to Solid Tumors
The approaches to cancer therapies that we should pay attention to are those capable of targeting many different types of cancer. The only practical way to meaningfully accelerate progress towards robust control of cancer as a whole is for the research community to prioritize treatments that have a much broader impact for a given investment in development. Chimeric antigen receptor (CAR) methods, in which T cells are engineered to direct their attention towards markers that identify cancer cells, can plausibly be adapted to many different cancers with minimal cost. Given that, they are a step in the right direction towards...
Source: Fight Aging! - April 25, 2017 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Telling Daughters About Their Genetic Breast Cancer Risk
We are now in the era of predictive medicine when many of us will have theopportunity to learn about our individual predisposition to develop serious diseases at some point in our lives. This is now a reality for families carrying the BRCA gene (females as well as males) (see:BRCA-Positive Males at Higher Risk for Prostate and Pancreatic Cancer). This topic was discussed in a recent article in theNew York Times. An excerpt from the article is listed below (see:When to Tell Daughters About a Genetic Breast Cancer Risk):As genetic testing has given women and men a trove o...
Source: Lab Soft News - April 25, 2017 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Industry News Clinical Lab Testing Lab Industry Trends Lab Information Medical Consumerism Medical Education Medical Ethics Source Type: blogs
Interview to Michael Seres, Patient Advocate and Founder of 11Health
By JOSE L. CÁNOVAS
Patient and Advocate and Founder of 11Health, Michael Seres is considered one of the strongest patient voices around the world, Michael Seres is involved in developing and implementing patient engagement strategies using digital technologies.
(Interview with Michael Seres by Smart Health)
At the age of 12, you were diagnosed with Crohn’s disease, an incurable bowel condition. Could you explain us your experience and how have you became a leader patient advocate?
At the age of 16 I was told by my gastroenterologist that the only way he would treat me is if we did this together as a team. I learnt very...
Source: The Health Care Blog - April 3, 2017 Category: Consumer Health News Authors: Matthew Holt Tags: Health 2.0 Health 2.0 Europe Michael Seres Smart Health Speaker Source Type: blogs
Emotional Stress
About a year ago, I met a young woman who had had cancer since age 18 when she was diagnosed with an inherited pancreatic cancer. She had never thought she would make it to 40. But last year she did make it to 39 so she had lots of hope. Until last fall when everything changed.In the fall, she found out nothing more could be done and she would be on hospice until the end. She got hospice at home and slowly began to decline. All of us who knew her were on pins and needles waiting and hoping. We got periodic updates on how she was doing. She was losing weight, she was not eating much, she wasn ' t getting out of bed much.The...
Source: Caroline's Breast Cancer Blog - April 2, 2017 Category: Cancer & Oncology Tags: cancer bonds death fridns hospice Source Type: blogs
Precision Medicine Is Our Best Hope In The Fight Against Cancer
In the fight against cancer, precision medicine is one of the most promising tools and the logical outcome of current healthcare trends. As start-ups offering personalized healthcare solutions multiply like mushrooms after rain, governments and regulatory agencies have to give appropriate responses in regulating the grass-root healthcare jungle. Here is my analysis about the potential and dilemmas about precision medicine.
Precision medicine is the logical outcome of modern healthcare
There is one phrase, which is not part of the Hippocratic Oath, but everyone in medicine knows it. Primum non nocere, meaning “first do n...
Source: The Medical Futurist - March 30, 2017 Category: Information Technology Authors: nora Tags: Future of Medicine Genomics Healthcare Design Personalized Medicine AI cancer cancer research chemotherapy digital gc4 genetics Genome Innovation oncology precision medicine targeted treatment technology Source Type: blogs
